Cortex Pharmaceuticals Inc. (COR) Posts Q4, FY 2009 Financials
Cortex Pharmaceuticals Inc. is a California-based neuroscience company focused on novel drug therapies for neurological and psychiatric disorders. The company recently posted its fourth quarter and full year financial results, as well as recent developments. Cortex reported a net loss applicable to common stock of $1,599,000, or $0.02 per share, for the quarter ended December 31, 2009, compared with a net loss of $3,130,000, or $0.07 per share, for the same three-month period of 2008. For the fiscal year ended December 31, 2009, Cortex reported a net loss applicable to common stock of $10,788,000, or $0.19 per share, compared to…